Company Overview and News


Add LXRP
to your dashboard

Headline News

NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid

2017-11-06 marketwired
VANCOUVER, BC--(Marketwired - November 06, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation ("Ambarii") CBD products, Naturally Splendid USA ("Naturally Splendid"), expects final approval imminently from the Japanese government for distribution of CBD products in Japan. (5-0)

3 Marijuana Stocks To Watch On Friday

2017-11-04 accesswire
CORAL GABLES, FL / ACCESSWIRE / November 3, 2017 / The legal marijuana industry is projected to achieve a compound annual growth of 25% to hit $20 billion in the next 4 years. It's no surprise that the marijuana industry is one of the most dynamic and rapidly growing industries throughout the United States and Canada. With that being said, here are three active marijuana stocks to have on your watch-list on Friday. (24-0)

NetworkNewsWire Announces Publication on the Wide-Ranging Potential of Patented Technology for Improved Bioabsorption

2017-11-04 marketwired
NEW YORK, NY--(Marketwired - Nov 3, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. (5-0)

Lexaria Bioscience Acquires 100% Ownership of Poviva Tea LLC

2017-11-02 accesswire
KELOWNA, BC / ACCESSWIRE / November 2, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces it has acquired 100% ownership interest in its majority-owned subsidiary Poviva Tea, LLC. (20-1)

Lexaria Announces Public Webinar November 1

2017-10-27 accesswire
KELOWNA, BC / ACCESSWIRE / October 27, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it will host its first-ever corporate web-meeting November 1, 2017 at 1:15PM Pacific, (4:15PM Eastern). The Company will deliver all our latest news and a short corporate presentation. A question and answer session will follow and as many questions will be taken as time allows. (20-0)

How To Get Rich Quick: Rise Early, Work Late, Discover (Cannabis) Oil

2017-10-18 seekingalpha
In Canada, sales of cannabis oil recently exceeded sales of dried cannabis by weight for the first time. Given the negative connotations of smoking, I think this trend will continue. (28-0)

September 18th Has Passed - Expect Canadian Cannabis Stocks To Rally Now

2017-10-02 seekingalpha
For the past three weeks, I have been looking for four factors to come together as an indication the Canadian cannabis stocks are about to rally. This has happened. (28-2)

Lexaria Announces Upcoming Public Events and Warrant Exercise

2017-09-22 accesswire
KELOWNA, BC / ACCESSWIRE / September 22, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it will be attending and delivering a presentation at the upcoming Canadian Securities Exchange sponsored "Cannabis in the Capital Markets" event on September 27, in Kelowna, British Columbia. Also presenting at the event will be Dr. Philip Ainsle, Co-Director of the Centre for Heart, Lung and Vascular Health, UBC Okanagan Campus, Kelowna, Canada, who will be Principal Investigator of the previously announce clinical study to be conducted by UBC and Lexaria. (20-0)

NetworkNewsWire Announces Publication Highlighting Recent Developments in Drug Delivery Technologies

2017-09-20 marketwired
NEW YORK, NY--(Marketwired - Sep 20, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. (5-0)

Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects

2017-09-19 prnewswire
The hazards of pharmacology have hardly changed since Paracelsus, a famous Renaissance physician, astoundingly declared that it was only the dosage that separated a medicine from a poison, bundled with adverse side effects. Despite considerable advances in medicine, many medications are still as injurious as their Renaissance precursors. Nevertheless, recent developments in drug delivery technologies increasingly suggest that safer, more efficient treatment options are on the horizon. (49-1)

Latest Health Canada Report Is Good News For Licensed Producers

2017-09-15 seekingalpha
The number of registered patients rises to 201,398 or an increase of 20% in the last three months. This is the basic industry driver for Canadian cannabis companies. (0-1)

Expect An Upturn In Canadian Cannabis Stocks After September 18th

2017-09-13 seekingalpha
The Canadian cannabis stocks have been in the doldrums for most of 2017 but a breakout may be on the horizon.

NetworkNewsWire Announces Publication Highlighting Companies Taking Innovative Strides in the Tobacco Industry

2017-08-17 marketwired
NEW YORK, NY--(Marketwired - Aug 17, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids.

FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators

2017-08-16 prnewswire
The black cloud over Big Tobacco has been swirling for decades, but few developments have cast a bigger shadow than the U.S. Food and Drug Administration's recent proposal to reduce nicotine levels in cigarettes to non-addictive levels. The new plan[1], originally unveiled on July 28, is expected to serve as a multi-year roadmap aimed at saving lives and significantly reducing the effects of tobacco-related diseases.

Lexaria Announces Exercised Warrants and Options

2017-08-16 accesswire
KELOWNA, BC / ACCESSWIRE / August 16, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it has received US$91,443.50 from the exercise of warrants and options previously granted. The stock warrants were exercised at the price of US$0.14 and the stock options were exercised at US$0.2273 for a total of 636,025 common shares being issued. All warrants and options are being exercised by third parties who are neither officers nor directors of the Company.

CUSIP: 52886N307